课题基金 / 基金详情

Mitochondrial Dynamics and Metabolism in Pulmonary Arterial Hypertension

Mitochondrial Dynamics and Metabolism in Pulmonary Arterial Hypertension
肺动脉高压的线粒体动力学和代谢
批准号:
312931
负责人:
Archer Stephen L
金额:
$288.67万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-09-01 至 2021-09-01

项目摘要

项目成果

Archer Stephen L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
<html> <body> <p>PAH is a disease of the cardiopulmonary unit (PA circulation and RV). PAH cells, including smooth muscle cells, have a cancer-like, proliferative, apoptosis-resistant, metabolically reprogrammed phenotype<sup>12</sup><sup>,</sup><sup>20
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Dynamin 2 expression, mitochondrial targeting, and evaluation of its role in mitochondrial fission: Implications for pulmonary arterial hypertension
The Role of Mitochondria and the NLRP3 Inflammasome in Right Ventricular Failure in Pulmonary Arterial Hypertension
Targeting the mitochondria in COVID-19 pneumonia: The cardiopulmonary effects of a SARS-CoV-2 mitochondriopathy
海外基金